Olema Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,884 | $0 |
Gross Profit | -94 | -88 | 1,796 | -90 |
EBITDA | -33,436 | -34,251 | -30,328 | -23,252 |
EBIT | -33,530 | -34,339 | -30,416 | -23,342 |
Net Income | -30,382 | -30,970 | -26,772 | -21,502 |
Net Change In Cash | 0 | 0 | 1,884 | 0 |
Free Cash Flow | -27,561 | -23,649 | -18,476 | -22,744 |
Cash | 16,892 | 33,720 | 68,539 | 117,407 |
Basic Shares | 56,282 | 55,574 | 54,783 | 44,977 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -377 | -1,658 | -1,663 | -11 |
EBITDA | -104,584 | -106,631 | -71,096 | -21,468 |
EBIT | -104,961 | -106,988 | -72,759 | -21,479 |
Net Income | -96,655 | -102,586 | -70,886 | -22,763 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 9,890 | -324,737 | ||
Free Cash Flow | -83,727 | -82,428 | -52,265 | -19,922 |
Cash | 68,539 | 23,702 | 287,250 | 338,549 |
Basic Shares | 45,247 | 39,995 | 39,524 | 39,308 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.54 |
2024-03-31 | -$0.56 |
2023-12-31 | -$0.49 |
2023-09-30 | -$0.48 |
